Pharming (PHAR) Net Margin (2020 - 2025)
Historic Net Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 122.39%.
- Pharming's Net Margin rose 1071400.0% to 122.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.39%, marking a year-over-year increase of 70200.0%. This contributed to the annual value of 78.41% for FY2024, which is 123700.0% up from last year.
- Per Pharming's latest filing, its Net Margin stood at 122.39% for Q3 2025, which was up 1071400.0% from 5.82% recorded in Q2 2025.
- Pharming's Net Margin's 5-year high stood at 122.39% during Q3 2025, with a 5-year trough of 34428.84% in Q1 2023.
- For the 5-year period, Pharming's Net Margin averaged around 3065.45%, with its median value being 22.39% (2024).
- As far as peak fluctuations go, Pharming's Net Margin tumbled by -217397500bps in 2022, and later soared by 344064500bps in 2024.
- Pharming's Net Margin (Quarter) stood at 16.09% in 2021, then plummeted by -2367bps to 364.66% in 2022, then grew by 24bps to 277.87% in 2023, then increased by 12bps to 245.13% in 2024, then surged by 150bps to 122.39% in 2025.
- Its Net Margin was 122.39% in Q3 2025, compared to 5.82% in Q2 2025 and 18.61% in Q1 2025.